@article{Masanori Emoto2017EJ16-0365, title={Pancreatic safety in Japanese patients with type 2 diabetes treated with once weekly dulaglutide 0.75 mg up to 52 weeks in phase 3 clinical trials}, author={Masanori Emoto and Tomonori Oura and Akiko Matsui and Hirotaka Kazama and Noriyuki Iwamoto}, journal={Endocrine Journal}, volume={64}, number={2}, pages={191-206}, year={2017}, doi={10.1507/endocrj.EJ16-0365} }